BSE filing, BSE: 544231. Summary written from the filing by ALFA Finder's alert engine.
Broach Lifecare Hospital Ltd: key numbers
- Share price
- ₹12.70
- Market cap
- ₹7.71 Cr
- Revenue (annual)
- ₹5.99 Cr
- Net profit (annual)
- ₹0.09 Cr
- P/E (TTM)
- 88.8×Sector 34.0×
- Promoter holding
- 63.76%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Broach Lifecare Hospital Ltd
All →Broach Lifecare Hospital Board Meeting Date
Broach Lifecare Hospital intimated BSE that its Board Meeting is scheduled for 31 Oct 2026 to consider half-year unaudited results. No other material decision has been announced yet.
Broach Lifecare Hospital Business Update
Broach Lifecare Hospital has secured empanelment with ONGC and ESIC. Additionally, it expanded PMJAY services and completed its NABH accreditation inspection.
- dialysis unit
- 5.0 beds
Broach Lifecare Hospital Management Change
Broach Lifecare Hospital Limited has appointed M/s. Rahul S Mithaiwala & Co. as the company's Secretarial Auditor effective September 30, 2026.
Broach Lifecare Hospital Other Announcement
Broach Lifecare Hospital Limited announced the appointment of M/s. Rahul Mithaiwala & Co. as the company's Secretarial Auditor for a five-year term.
Broach Lifecare Hospital Annual General Meeting
Broach Lifecare Hospital Ltd held its 3rd Annual General Meeting on September 30, 2026, through video conferencing to transact ordinary and special business.
Broach Lifecare Hospital Management Change
Broach Lifecare Hospital Ltd submitted the CFO's resignation letter following a BSE query, addressing an inadvertent omission from its previous disclosure regarding the management change.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.